Company intelligence / Profile preview

Guilin Tianhe Pharmaceutical

Guilin, Guangxi Province, China999.com.cn ↗

Ownership: Private
Development stage: Other

Overview

Jinbuhuan Gutong Capsule has reached Phase 2 clinical trials for osteoarthritis of the knee. The company’s flagship over-the-counter products—such as hard/soft plasters—are widely used in China and have achieved significant market share in their category. No recent large-scale international clinical trial results were found.

Therapeutic areas: HematologyRheumatology
Modalities: Herbal medicineSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Guilin Tianhe Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guilin Tianhe Pharmaceutical.